Management of Adrenal Emergency in Germany
MAdEy
1 other identifier
observational
150
0 countries
N/A
Brief Summary
The management of adrenal crisis is often problematic and the time to adequate treatment is frequently delayed.The aim of the study is to evaluate the management of adrenal emergencies requiring parenteral glucocorticoid treatment by a prospective multicenter study in patients with chronic adrenal insufficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 18, 2018
CompletedFirst Posted
Study publicly available on registry
February 8, 2018
CompletedFebruary 8, 2018
February 1, 2018
2 years
January 18, 2018
February 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Median time from contacting a medical professional to arrival of professional medical help
Evaluation of the median time (in minutes) from contacting a medical professional (by the patient) to arrival of professional medical help during an (adrenal) emergency. The time is documented in a questionnaire by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.
6-36 months
Median time from showing the emergency card (by a patient) to glucocorticoid-injection by a medical professional
Evaluation of the median time (in minutes) from showing the emergency card (by a patient) to glucocorticoid-injection by a medical professional. The time is documented in a questionnaire by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.
6-36 months
Median time from the beginning of symptoms to glucocorticoid-injection
Evaluation of the median time (in minutes) from the beginning of symptoms to glucocorticoid-injection during an (adrenal) emergency. The time is documented in a questionnaire by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.
6-36 months
Duration of hospitalisation (number of days at a hospital)
Evaluation of the duration of hospitalisation (number of days at a hospital) due to an adrenal emergency. The number of days is documented by the patients themselves (directly after the adrenal emergency). The data of all patients will be stated as median and range.
6-36 months
Number of patients that received an intramuscular glucocorticoid-injection
Evaluation of the number of patients that received an intramuscular glucocorticoid-injection (compared to subcutaneous administration) during an adrenal emergency. Documentation by the patients themselves directly after the adrenal emergency.
6-36 months
Secondary Outcomes (5)
Cause of the adrenal emergency
6-36 months
Median time from the beginning of symptoms to oral dose adjustment (glucocorticoids) during an adrenal emergency
6-36 months
Median time from the beginning of symptoms to contacting a medical professional
6-36 months
Symptoms of the adrenal emergency
6-36 months
Median amount of additionally oral ingested glucocorticoids during the adrenal emergency
6-36 months
Interventions
No intervention
Eligibility Criteria
Patients aged ≥18 years with a documented chronic adrenal insufficiency under established corticosteroid replacement therapy.
You may qualify if:
- Age ≥18 years
- Documented chronic adrenal insufficiency
- Established corticosteroid replacement therapy
- Written informed consent
You may not qualify if:
- \- Age \<18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M, Allolio B. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015 Feb;100(2):407-16. doi: 10.1210/jc.2014-3191. Epub 2014 Nov 24.
PMID: 25419882BACKGROUNDHahner S, Hemmelmann N, Quinkler M, Beuschlein F, Spinnler C, Allolio B. Timelines in the management of adrenal crisis - targets, limits and reality. Clin Endocrinol (Oxf). 2015 Apr;82(4):497-502. doi: 10.1111/cen.12609. Epub 2014 Nov 6.
PMID: 25200922BACKGROUNDAllolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol. 2015 Mar;172(3):R115-24. doi: 10.1530/EJE-14-0824. Epub 2014 Oct 6.
PMID: 25288693BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2018
First Posted
February 8, 2018
Study Start
November 1, 2015
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
February 8, 2018
Record last verified: 2018-02